Segmentation by type differentiates devices according to form factor, integration level, and intended workflow, each exerting distinct pressure on the market size. Portable units, comprising roughly 40 % of shipments, are valued for bedside flexibility and rapid deployment in emergency or field settings; their lightweight design and battery operation enable use outside fixed infrastructure, expanding the addressable user base. Desktop systems, representing about 35 % of sales, remain the workhorse in tertiary hospitals where high‑resolution displays, advanced signal processing, and extensive connectivity are required for comprehensive cardiac assessment. Integrated solutions—often embedded within multi‑parameter monitoring platforms—account for 20 % of the market, reflecting a trend toward consolidated bedside equipment that reduces space and maintenance costs. A niche but growing wearable category, at 5 %, targets continuous ambulatory monitoring and leverages wireless telemetry to feed real‑time analytics. These type distinctions shape R&D investment, supply chain complexity, and pricing tiers across the Digital 18-Lead Electrocardiograph market.